MedComm
medcomm.bsky.social
MedComm
@medcomm.bsky.social
MedComm is a peer‐reviewed, online OA journal that publishes the pioneer works of medicine on the basis of novelty, timeliness and significance on human health.
Pinned
🎉Congratulations!

In the recently released JCR Impact Factor 2024, MedComm maintained an IF of 10.7, placing it in the Q1 category for Medicine, Research & Experimental, ranking 14/195. Welcome to submit your next manuscripts to MedComm!

#JCR2025 #TrustedJournals #ImpactFactor
#Article in #MedComm
CD36 Inhibits Triple-Negative Breast Cancer Progression by Transcriptionally Upregulating Caveolin-1 and Promoting Lipid-Reactive Oxygen Species-Related Ferroptosis doi.org/10.1002/mco2...

#caveolin_1 #CD36 #ferroptosis #TNBC #CAV1
CD36 Inhibits Triple‐Negative Breast Cancer Progression by Transcriptionally Upregulating Caveolin‐1 and Promoting Lipid‐Reactive Oxygen Species‐Related Ferroptosis
CD36 is identified as a key suppressor in triple-negative breast cancer (TNBC). It inhibits tumor metastasis by promoting ferroptosis via the CD36–CAV1–lipid peroxidation axis. Multiomics and metasta...
doi.org
November 20, 2025 at 9:37 AM
#Letter in #MedComm
#Metabolic #Reprogramming for Body Adaptation and Inflammatory Control in Eccentric Damaging Exercise: Comprehensive Molecular Insights From Repeated Downhill Running doi.org/10.1002/mco2...

#TCA #CK #CreatineKinase #myoglobin #HRMS
November 20, 2025 at 9:29 AM
#Review in #MedComm
Protein Kinase C Family: Structures, Biological Functions, Diseases, and Pharmaceutical Interventions doi.org/10.1002/mco2...

#AutoimmunePathologies #cancer #phosphorylation #PKC #TherapeuticTarget
November 20, 2025 at 9:26 AM
#Article in #MedComm
Incidence, Risk Factors, and Epidemiological Trends of Head and Neck Cancer: A Global Analysis doi.org/10.1002/mco2...

#distribution #HNC #RiskFactor #TemporalTrend
Incidence, Risk Factors, and Epidemiological Trends of Head and Neck Cancer: A Global Analysis
Global incidence of head and neck cancer by regions in 2022.
doi.org
November 20, 2025 at 9:22 AM
#Review in #MedComm_Oncology
Targeting Metabolic Reprogramming in Tumor: From Mechanisms to Precision Immunotherapies doi.org/10.1002/mog2...

#ImmuneResponse #immunotherapy #MetabolicReprogramming #TME
November 20, 2025 at 9:16 AM
#Letter in @MedComm_MC
Size Matters: Small Circulating Tumor Cells Indicate Worse Therapy Response in Breast Cancer doi.org/10.1002/mco2...

#CellMorphology #CirculatingTumorCells #FlowCytometry #TherapyResponse
November 14, 2025 at 3:45 AM
#Article in #MedComm
#Exosomal Long Interspersed Nuclear Element-1 Analytes Discriminate Histologic Subtypes, Sex, and Clinicopathological Characteristics of Patients with Non-Small Cell Lung #Cancer doi.org/10.1002/mco2..., studied by a team from @CenterTexas

#biomarker
Exosomal Long Interspersed Nuclear Element‐1 Analytes Discriminate Histologic Subtypes, Sex, and Clinicopathological Characteristics of Patients with Non‐Small Cell Lung Cancer
Exosomal long interspersed nuclear element-1 (LINE-1) analytes exhibit distinct expression profiles across histologic subtypes of non-small cell lung cancer (NSCLC) and demonstrate significant associ...
doi.org
November 14, 2025 at 2:53 AM
#Article in #MedComm
Aberrant Expression of A Disintegrin and Metalloproteinase With Thrombospondin Motifs 13 (ADAMTS13) in Pancreatic Cancer Leads to Dichotomic Functions doi.org/10.1002/mco2...

#ADAMTS13 #adipokine #pancreas #PDAC #PeripancreaticAdipose #vascularization
Aberrant Expression of A Disintegrin and Metalloproteinase With Thrombospondin Motifs 13 (ADAMTS13) in Pancreatic Cancer Leads to Dichotomic Functions
Allmang et al. demonstrated that ADAMTS13 is overexpressed in PDAC, associated with prolonged survival and reduced vascular density. Knockout of ADAMTS13 in PDAC cells led to a decrease in migration ...
doi.org
November 14, 2025 at 2:28 AM
#Article in #MedComm

First-Line Third-Generation #EGFR Tyrosine Kinase Inhibitor Monotherapy for Advanced EGFR-Mutated Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis doi.org/10.1002/mco2...

#MetaAnalysis #NSCLC #TKI #FirstLine #TRAE #Monotherapy
First‐Line Third‐Generation EGFR Tyrosine Kinase Inhibitor Monotherapy for Advanced EGFR‐Mutated Non‐Small Cell Lung Cancer: A Systematic Review and Network Meta‐Analysis
Third-generation EGFR-TKIs are the current first-line standard for advanced EGFR-mutated NSCLC. While all improve PFS versus first-generation TKIs, no significant PFS or ORR differences exist among t...
doi.org
November 14, 2025 at 2:04 AM
#Review in #MedComm_Biomatrials_and_Applications
Modular Nanosensing Platforms for Tuberculosis and Beyond: Engineering Biomaterials Toward Cross-Pathogen Diagnostic Universality doi.org/10.1002/mba2...

#cross_pathogen #diagnostic #modular #nanosensing #platforms #nanobiosensor
November 14, 2025 at 1:50 AM
🎉Congratulations!

In the recently released JCR Impact Factor 2024, MedComm maintained an IF of 10.7, placing it in the Q1 category for Medicine, Research & Experimental, ranking 14/195. Welcome to submit your next manuscripts to MedComm!

#JCR2025 #TrustedJournals #ImpactFactor
November 7, 2025 at 8:36 AM
#Article in #MedComm
Chidamide (a Histone Deacetylase Inhibitor) Plus Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Phase Ib Trial doi.org/10.1002/mco2...
#Clinicaltrial #EpigeneticRegulation #HistoneDeacetylase #mCRPC
Chidamide (a Histone Deacetylase Inhibitor) Plus Abiraterone in Metastatic Castration‐Resistant Prostate Cancer (mCRPC): A Phase Ib Trial
Metastatic castration-resistant prostate cancer (mCRPC) remains challenging. This Phase Ib trial tested chidamide, a selective HDAC inhibitor, plus abiraterone in 18 patients. The regimen was well to...
doi.org
November 7, 2025 at 8:21 AM
#Article in #MedComm @wiley.com
Synthesized Depside Molecules Suppress the Progression of Colorectal Cancer by Binding VDAC1/PHB/MMP9 Being at the Crossroads of Stemness, Motility, Apoptosis, and Metabolism doi.org/10.1002/mco2...

#MMP #prohibitin1 #VDAC1 #probe #BindingIdentification
Synthesized Depside Molecules Suppress the Progression of Colorectal Cancer by Binding VDAC1/PHB/MMP9 Being at the Crossroads of Stemness, Motility, Apoptosis, and Metabolism
This study suggests that newly synthesized depside compounds suppress the progression of colorectal cancer by directly targeting VDAC1/PHB/MMP9. Especially, SB4 demonstrated significant bioavailabili...
doi.org
November 7, 2025 at 8:19 AM